All News #Library
Biotech
Lilly inks OliX deals to expand in MASH
11 Feb 2025 //
BUSINESSWIRE
OliX Administers First Patient in Phase 1 Clinical Study of OLX72021
13 Jun 2023 //
BUSINESSWIRE
OliX Presents Data Showing Weight Loss from anti-NASH siRNA and Semaglutide
11 May 2023 //
BUSINESSWIRE
OliX Inks MOU with DynamiCure Biotechnology to Develop ADC Immunotherapy
10 May 2023 //
BUSINESSWIRE
OliX Announces Results from a Phase 2a Trial of OLX10010 for Hypertrophic Scar
28 Apr 2023 //
BUSINESSWIRE
OliX Doses First Patient in Clinical Trial for RNAi Therapeutic OLX10212
27 Mar 2023 //
BUSINESSWIRE

Market Place
Sourcing Support